
Genfit's up to €185M royalty deal; J&J’s Tremfya gets a Crohn's approval
Plus, news about Akeso, Pulmatrix, Autolus, MacroGenics and BlissBio:
Genfit completes up to €185M royalty deal: Per the agreement with HealthCare Royalty, the company …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.